The role of the oral microbiota in the causal effect of adjunctive antibiotics on clinical outcomes in stage III-IV periodontitis patients.
Humans
Amoxicillin
/ therapeutic use
Metronidazole
/ therapeutic use
Anti-Bacterial Agents
/ therapeutic use
Microbiota
/ drug effects
Female
Male
Adult
Middle Aged
Periodontitis
/ microbiology
Treatment Outcome
Mouth
/ microbiology
Dysbiosis
/ microbiology
Dental Plaque
/ microbiology
Bacteria
/ classification
Antibiotic treatment
Clinical attachment loss
Clinical outcomes
Directed acyclic graphs
Dysbiosis
Microbial communities
Normobiotic
Oral microbiota
Periodontitis
Subgingival plaque
Journal
Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147
Informations de publication
Date de publication:
26 Oct 2024
26 Oct 2024
Historique:
received:
17
04
2024
accepted:
07
10
2024
medline:
27
10
2024
pubmed:
27
10
2024
entrez:
27
10
2024
Statut:
epublish
Résumé
Periodontitis, a prevalent chronic inflammatory disease, offers insights into the broader landscape of chronic inflammatory conditions. The progression and treatment outcomes of periodontitis are closely related to the oral microbiota's composition. Adjunctive systemic Amoxicillin 500 mg and Metronidazole 400 mg, often prescribed thrice daily for 7 days to enhance periodontal therapy's efficacy, have lasting effects on the oral microbiome. However, the precise mechanism through which the oral microbiome influences clinical outcomes in periodontitis patients remains debated. This investigation explores the pivotal role of the oral microbiome's composition in mediating the outcomes of adjunctive systemic antibiotic treatment. Subgingival plaque samples from 10 periodontally healthy and 163 periodontitis patients from a randomized clinical trial on periodontal therapy were analyzed. Patients received either adjunctive amoxicillin/metronidazole or a placebo after mechanical periodontal treatment. Microbial samples were collected at various intervals up to 26 months post-therapy. Using topic models, we identified microbial communities associated with normobiotic and dysbiotic states, validated with 86 external and 40 internal samples. Logistic regression models evaluated the association between these microbial communities and clinical periodontitis parameters. A Directed Acyclic Graph (DAG) determined the mediating role of oral microbiota in the causal path of antibiotic treatment effects on clinical outcomes. We identified clear distinctions between dysbiotic and normobiotic microbial communities, differentiating healthy from periodontitis subjects. Dysbiotic states consistently associated with below median %Pocket Probing Depth ≥ 5 mm (OR = 1.26, 95% CI [1.14-1.42]) and %Bleeding on Probing (OR = 1.09, 95% CI [1.00-1.18]). Factors like microbial response to treatment, smoking, and age were predictors of clinical attachment loss progression, whereas sex and antibiotic treatment were not. Further, we showed that the oral microbial treatment response plays a crucial role in the causal effect of antibiotic treatment on clinical treatment outcomes. The shift towards a normobiotic subgingival microbiome, primarily induced by adjunctive antibiotics, underscores the potential for microbiome-targeted interventions to enhance therapeutic efficacy in chronic inflammatory conditions. This study reaffirms the importance of understanding the oral microbiome's role in periodontal health and paves the way for future research exploring personalized treatment strategies based on individual microbiome profiles. Video Abstract.
Sections du résumé
BACKGROUND
BACKGROUND
Periodontitis, a prevalent chronic inflammatory disease, offers insights into the broader landscape of chronic inflammatory conditions. The progression and treatment outcomes of periodontitis are closely related to the oral microbiota's composition. Adjunctive systemic Amoxicillin 500 mg and Metronidazole 400 mg, often prescribed thrice daily for 7 days to enhance periodontal therapy's efficacy, have lasting effects on the oral microbiome. However, the precise mechanism through which the oral microbiome influences clinical outcomes in periodontitis patients remains debated. This investigation explores the pivotal role of the oral microbiome's composition in mediating the outcomes of adjunctive systemic antibiotic treatment.
METHODS
METHODS
Subgingival plaque samples from 10 periodontally healthy and 163 periodontitis patients from a randomized clinical trial on periodontal therapy were analyzed. Patients received either adjunctive amoxicillin/metronidazole or a placebo after mechanical periodontal treatment. Microbial samples were collected at various intervals up to 26 months post-therapy. Using topic models, we identified microbial communities associated with normobiotic and dysbiotic states, validated with 86 external and 40 internal samples. Logistic regression models evaluated the association between these microbial communities and clinical periodontitis parameters. A Directed Acyclic Graph (DAG) determined the mediating role of oral microbiota in the causal path of antibiotic treatment effects on clinical outcomes.
RESULTS
RESULTS
We identified clear distinctions between dysbiotic and normobiotic microbial communities, differentiating healthy from periodontitis subjects. Dysbiotic states consistently associated with below median %Pocket Probing Depth ≥ 5 mm (OR = 1.26, 95% CI [1.14-1.42]) and %Bleeding on Probing (OR = 1.09, 95% CI [1.00-1.18]). Factors like microbial response to treatment, smoking, and age were predictors of clinical attachment loss progression, whereas sex and antibiotic treatment were not. Further, we showed that the oral microbial treatment response plays a crucial role in the causal effect of antibiotic treatment on clinical treatment outcomes.
CONCLUSIONS
CONCLUSIONS
The shift towards a normobiotic subgingival microbiome, primarily induced by adjunctive antibiotics, underscores the potential for microbiome-targeted interventions to enhance therapeutic efficacy in chronic inflammatory conditions. This study reaffirms the importance of understanding the oral microbiome's role in periodontal health and paves the way for future research exploring personalized treatment strategies based on individual microbiome profiles. Video Abstract.
Identifiants
pubmed: 39462428
doi: 10.1186/s40168-024-01945-3
pii: 10.1186/s40168-024-01945-3
doi:
Substances chimiques
Amoxicillin
804826J2HU
Metronidazole
140QMO216E
Anti-Bacterial Agents
0
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
220Informations de copyright
© 2024. The Author(s).
Références
Abusleme L, Hoare A, Hong B-Y, Diaz PI. Microbial signatures of health, gingivitis, and periodontitis. Periodontology 2000. 2021;86(1):57–78. https://doi.org/10.1111/prd.12362 .
doi: 10.1111/prd.12362
pubmed: 33690899
Àlvarez G, Arredondo A, Isabal S, Teughels W, Laleman I, Contreras MJ, Isbej L, Huapaya E, Mendoza G, Mor C, Nart J, Blanc V, León R. Association of nine pathobionts with periodontitis in four South American and European countries. J Oral Microbiol. 2023;15(1):2188630. https://doi.org/10.1080/20002297.2023.2188630 .
doi: 10.1080/20002297.2023.2188630
pubmed: 36950255
pmcid: 10026778
Belibasakis, G. N., Belstrøm, D., Eick, S., Gursoy, U. K., Johansson, A., & Könönen, E. (2023). Periodontal microbiology and microbial etiology of periodontal diseases: historical concepts and contemporary perspectives. Periodontology 2000, prd.12473. https://doi.org/10.1111/prd.12473
Belibasakis GN, Bostanci N, Marsh PD, Zaura E. Applications of the oral microbiome in personalized dentistry. Arch Oral Biol. 2019;104:7–12. https://doi.org/10.1016/j.archoralbio.2019.05.023 .
doi: 10.1016/j.archoralbio.2019.05.023
pubmed: 31153099
Berglundh T, Krok L, Liljenberg B, Westfelt E, Serino G, Lindhe J. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. J Clin Periodontol. 1998;25(5):354–62. https://doi.org/10.1111/j.1600-051X.1998.tb02455.x .
doi: 10.1111/j.1600-051X.1998.tb02455.x
pubmed: 9650870
Bizzarro S, Laine ML, Buijs MJ, Brandt BW, Crielaard W, Loos BG, Zaura E. Microbial profiles at baseline and not the use of antibiotics determine the clinical outcome of the treatment of chronic periodontitis. Sci Rep. 2016;6(1):20205. https://doi.org/10.1038/srep20205 .
doi: 10.1038/srep20205
pubmed: 26830979
pmcid: 4735321
Blei DM. Probabilistic topic models. Commun ACM. 2012;55(4):77–84. https://doi.org/10.1145/2133806.2133826 .
doi: 10.1145/2133806.2133826
Borges I, Faveri M, Figueiredo LC, Duarte PM, Retamal-Valdes B, Montenegro SCL, Feres M. Different antibiotic protocols in the treatment of severe chronic periodontitis: a 1-year randomized trial. J Clin Periodontol. 2017;44(8):822–32. https://doi.org/10.1111/jcpe.12721 .
doi: 10.1111/jcpe.12721
pubmed: 28303587
Bürkner, P.-C. (2017). brms: an R package for Bayesian multilevel models using Stan. Journal of Statistical Software, 80(1). https://doi.org/10.18637/jss.v080.i01
Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–3. https://doi.org/10.1038/nmeth.3869 .
doi: 10.1038/nmeth.3869
pubmed: 27214047
pmcid: 4927377
Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, Knights D, Gajer P, Ravel J, Fierer N, Gordon JI, Knight R. Moving pictures of the human microbiome. Genome Biol. 2011;12(5):R50. https://doi.org/10.1186/gb-2011-12-5-r50 .
doi: 10.1186/gb-2011-12-5-r50
pubmed: 21624126
pmcid: 3271711
Chen T, Marsh PD, Al-Hebshi NN. SMDI: an index for measuring subgingival microbial dysbiosis. J Dent Res. 2022;101(3):331–8. https://doi.org/10.1177/00220345211035775 .
doi: 10.1177/00220345211035775
pubmed: 34428955
Chen, T., Yu, W.-H., Izard, J., Baranova, O. V., Lakshmanan, A., & Dewhirst, F. E. (2010). The human oral microbiome database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database, 2010(0), baq013–baq013. https://doi.org/10.1093/database/baq013
Dilber E, Hagenfeld D, Ehmke B, Faggion CM. A systematic review on bacterial community changes after periodontal therapy with and without systemic antibiotics: an analysis with a wider lens. J Periodontal Res. 2020;55(6):785–800. https://doi.org/10.1111/jre.12803 .
doi: 10.1111/jre.12803
pubmed: 32990996
Eickholz, P., Koch, R., Göde, M., Nickles, K., Kocher, T., Lorenz, K., Kim, T., Meyle, J., Kaner, D., Schlagenhauf, U., Harks, I., & Ehmke, B. (2023). Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis stage and grade: An exploratory sub‐analysis of the ABPARO trial. Journal of Clinical Periodontology, jcpe.13838. https://doi.org/10.1111/jcpe.13838
Eickholz P, Koch R, Kocher T, Hoffmann T, Kim T, Meyle J, Kaner D, Schlagenhauf U, Harmsen D, Harks I, Ehmke B. Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients’ age: an exploratory sub-analysis of the ABPARO trial. J Clin Periodontol. 2019;46(4):491–501. https://doi.org/10.1111/jcpe.13096 .
doi: 10.1111/jcpe.13096
pubmed: 30825384
pmcid: 6594242
Eickholz P, Nickles K, Koch R, Harks I, Hoffmann T, Kim T, Kocher T, Meyle J, Kaner D, Schlagenhauf U, Doering S, Gravemeier M, Ehmke B. Is furcation involvement affected by adjunctive systemic amoxicillin plus metronidazole? A clinical trials exploratory subanalysis. J Clin Periodontol. 2016;43(10):839–48. https://doi.org/10.1111/jcpe.12594 .
doi: 10.1111/jcpe.12594
pubmed: 27393928
Faveri M, Rebello A, de Oliveira Dias R, Borges-Junior I, Duarte PM, Figueiredo LC, Feres M. Clinical and microbiologic effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized chronic periodontitis: smokers versus non-smokers. J Periodontol. 2014;85(4):581–91. https://doi.org/10.1902/jop.2013.130278 .
doi: 10.1902/jop.2013.130278
pubmed: 23826648
Feres M, Bernal M, Matarazzo F, Faveri M, Duarte P, Figueiredo L. Subgingival bacterial recolonization after scaling and root planing in smokers with chronic periodontitis. Aust Dent J. 2015;60(2):225–32. https://doi.org/10.1111/adj.12225 .
doi: 10.1111/adj.12225
pubmed: 25283721
Feres M, Retamal-Valdes B, Faveri M, Duarte P, Shibli J, Soares GMS, Miranda T, Teles F, Goodson M, Hasturk H, Van Dyke T, Ehmke B, Eickholz P, Schlagenhauf U, Meyle J, Koch R, Kocher T, Hoffmann T, Kim T-S, Doyle H, et al. Proposal of a clinical endpoint for periodontal trials: the treat-to-target approach. J Int Acad Periodontol. 2020;22(2):41–53.
pubmed: 32224549
Feres M, Retamal-Valdes B, Fermiano D, Faveri M, Figueiredo LC, Mayer MPA, Lee J, Bittinger K, Teles F. Microbiome changes in young periodontitis patients treated with adjunctive metronidazole and amoxicillin. J Periodontol. 2021;92(4):467–78. https://doi.org/10.1002/JPER.20-0128 .
doi: 10.1002/JPER.20-0128
pubmed: 32844406
Fukuyama, J., Sankaran, K., & Symul, L. (2021). Multiscale analysis of count data through topic alignment. https://doi.org/10.48550/ARXIV.2109.05541
Griffen AL, Beall CJ, Campbell JH, Firestone ND, Kumar PS, Yang ZK, Podar M, Leys EJ. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J. 2012;6(6):1176–85. https://doi.org/10.1038/ismej.2011.191 .
doi: 10.1038/ismej.2011.191
pubmed: 22170420
Hagenfeld, D., Kleine Bardenhorst, S., Matern, J., Prior, K., Harks, I., Eickholz, P., Lorenz, K., Kim, T., Kocher, T., Meyle, J., Kaner, D., Schlagenhauf, U., Harmsen, D., & Ehmke, B. (2023). Long‐term changes in the subgingival microbiota in patients with stage III–IV periodontitis treated by mechanical therapy and adjunctive systemic antibiotics: a secondary analysis of a randomized controlled trial. Journal of Clinical Periodontology, jcpe.13824. https://doi.org/10.1111/jcpe.13824
Hagenfeld, D., Matern, J., Prior, K., Harks, I., Eickholz, P., Lorenz, K., Kim, T.-S., Kocher, T., Meyle, J., Kaner, D., Schlagenhauf, U., Harmsen, D., & Ehmke, B. (2020). Significant short-term shifts in the microbiomes of smokers with periodontitis after periodontal therapy with amoxicillin & metronidazole as revealed by 16S rDNA amplicon next generation sequencing. Frontiers in Cellular and Infection Microbiology, 10. https://doi.org/10.3389/fcimb.2020.00167
Hajishengallis, G. (2023). Illuminating the oral microbiome and its host interactions: animal models of disease. FEMS Microbiology Reviews, fuad018. https://doi.org/10.1093/femsre/fuad018
Hajishengallis, G., & Lamont, R. J. (2021). Polymicrobial communities in periodontal disease: Their quasi‐organismal nature and dialogue with the host. Periodontology 2000, 86(1), 210–230. https://doi.org/10.1111/prd.12371
Harks I, Harmsen D, Gravemeier M, Prior K, Koch R, Doering S, Petersilka G, Weniger T, Eickholz P, Hoffmann T, Kim T-S, Kocher T, Meyle J, Purucker P, Schlagenhauf U, Ehmke B. A concept for clinical research triggered by suggestions from systematic reviews about adjunctive antibiotics. Appl Clin Res Clin Trials Regulat Affairs. 2014;1(1):43–50. https://doi.org/10.2174/2213476X01666140327211914 .
doi: 10.2174/2213476X01666140327211914
Harks I, Koch R, Eickholz P, Hoffmann T, Kim T, Kocher T, Meyle J, Kaner D, Schlagenhauf U, Doering S, Holtfreter B, Gravemeier M, Harmsen D, Ehmke B. Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial. J Clin Periodontol. 2015;42(9):832–42. https://doi.org/10.1111/jcpe.12441 .
doi: 10.1111/jcpe.12441
pubmed: 26250060
pmcid: 5054899
Joshi V, Matthews C, Aspiras M, de Jager M, Ward M, Kumar P. Smoking decreases structural and functional resilience in the subgingival ecosystem. J Clin Periodontol. 2014;41(11):1037–47. https://doi.org/10.1111/jcpe.12300 .
doi: 10.1111/jcpe.12300
pubmed: 25139209
Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016;375(24):2369–79. https://doi.org/10.1056/NEJMra1600266 .
doi: 10.1056/NEJMra1600266
pubmed: 27974040
Martin, M. (2011). Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.Journal, 17(1), 10. https://doi.org/10.14806/ej.17.1.200
Matarazzo F, Figueiredo LC, Cruz SEB, Faveri M, Feres M. Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2008;35(10):885–96. https://doi.org/10.1111/j.1600-051X.2008.01304.x .
doi: 10.1111/j.1600-051X.2008.01304.x
pubmed: 18727657
Mendes SDNC, Esteves CM, Mendes JAV, Feres M, Figueiredo N, De Miranda TS, Shibli JA, Figueiredo LC. Systemic antibiotics and chlorhexidine associated with periodontal therapy: microbiological effect on intraoral surfaces and saliva. Antibiotics. 2023;12(5):847. https://doi.org/10.3390/antibiotics12050847 .
doi: 10.3390/antibiotics12050847
pubmed: 37237750
pmcid: 10215836
Mestnik MJ, Feres M, Figueiredo LC, Soares G, Teles RP, Fermiano D, Duarte PM, Faveri M. The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012;39(10):955–61. https://doi.org/10.1111/j.1600-051X.2012.01932.x .
doi: 10.1111/j.1600-051X.2012.01932.x
pubmed: 22882646
Najmanova L, Sabova L, Lenartova M, Janatova T, Mysak J, Vetrovsky T, Tesinska B, Balikova Novotna G, Koberska M, Broukal Z, Duskova J, Podzimek S, Janata J. R/G value—a numeric index of individual periodontal health and oral microbiome dynamics. Front Cell Infect Microbiol. 2021;11:602643. https://doi.org/10.3389/fcimb.2021.602643 .
doi: 10.3389/fcimb.2021.602643
pubmed: 33777830
pmcid: 7988090
Nibali L, Sousa V, Davrandi M, Spratt D, Alyahya Q, Dopico J, Donos N. Differences in the periodontal microbiome of successfully treated and persistent aggressive periodontitis. J Clin Periodontol. 2020;47(8):980–90. https://doi.org/10.1111/jcpe.13330 .
doi: 10.1111/jcpe.13330
pubmed: 32557763
Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D. H., Flemmig, T. F., Garcia, R., Giannobile, W. V., Graziani, F., Greenwell, H., Herrera, D., Kao, R. T., Kebschull, M., Kinane, D. F., Kirkwood, K. L., Kocher, T., Kornman, K. S., Kumar, P. S., … Tonetti, M. S. (2018). Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions: classification and case definitions for periodontitis. Journal of Clinical Periodontology, 45, S162–S170. https://doi.org/10.1111/jcpe.12946
Pei J, Li F, Xie Y, Liu J, Yu T, Feng X. Microbial and metabolomic analysis of gingival crevicular fluid in general chronic periodontitis patients: Lessons for a predictive, preventive, and personalized medical approach. EPMA J. 2020;11(2):197–215. https://doi.org/10.1007/s13167-020-00202-5 .
doi: 10.1007/s13167-020-00202-5
pubmed: 32547651
pmcid: 7272536
Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glockner FO. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35(21):7188–96. https://doi.org/10.1093/nar/gkm864 .
doi: 10.1093/nar/gkm864
pubmed: 17947321
pmcid: 2175337
RStudio Team. RStudio: Integrated Development Environment for R. Boston: RStudio, Inc.; 2019. Available from: http://www.rstudio.com/ .
Symul L, Jeganathan P, Costello EK, France M, Bloom SM, Kwon DS, Ravel J, Relman DA, Holmes S. Sub-communities of the vaginal ecosystem in pregnant and non-pregnant women. Microbiology. 2021. https://doi.org/10.1101/2021.12.10.471327 .
Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(S22):257–81. https://doi.org/10.1111/jcpe.13264 .
doi: 10.1111/jcpe.13264
pubmed: 31994207
Textor, J., Van Der Zander, B., Gilthorpe, M. S., Liśkiewicz, M., & Ellison, G. T. H. (2017). Robust causal inference using directed acyclic graphs: The R package ‘dagitty.’ International Journal of Epidemiology, dyw341. https://doi.org/10.1093/ije/dyw341
Tomás I, Regueira-Iglesias A, López M, Arias-Bujanda N, Novoa L, Balsa-Castro C, Tomás M. Quantification by qPCR of pathobionts in chronic periodontitis: development of predictive models of disease severity at site-specific level. Front Microbiol. 2017;8:1443. https://doi.org/10.3389/fmicb.2017.01443 .
doi: 10.3389/fmicb.2017.01443
pubmed: 28848499
pmcid: 5552702
VanderWeele TJ. Mediation analysis: a practitioner’s guide. Annu Rev Public Health. 2016;37(1):17–32. https://doi.org/10.1146/annurev-publhealth-032315-021402 .
doi: 10.1146/annurev-publhealth-032315-021402
pubmed: 26653405
Zaura E, Keijser BJ, Huse SM, Crielaard W. Defining the healthy “core microbiome” of oral microbial communities. BMC Microbiol. 2009;9(1):259. https://doi.org/10.1186/1471-2180-9-259 .
doi: 10.1186/1471-2180-9-259
pubmed: 20003481
pmcid: 2805672